Cite Filings / ALZN
Feed Companies Filings Check
Sign in

CIK 0001677077

  • Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
811822909
Phone
+1 844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
Filings Financials Insiders Search text
All 401 Financials 96 Shareholder Meetings 12 Executive Compensation 86 Insider Trading 170 Beneficial Ownership Interest 18 Business Combinations 74 Public Offerings 52 Regulation A Offering 25 Mutual Funds and ETFs 6 Others 34
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2021-05-25
  3. S-1/A Offering Registration Statement 2021-05-25
  4. UPLOAD Other SEC-generated Letter 2021-05-20
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2021-05-10
  6. S-1 Offering Registration Statement 2021-05-10
  7. UPLOAD Other SEC-generated Letter 2021-04-20
  8. UPLOAD Other SEC-generated Letter 2021-01-25
  9. CORRESP Other Correspondence Between Filers and SEC Staff 2016-12-06
  10. CORRESP Other Correspondence Between Filers and SEC Staff 2016-10-20
  11. UPLOAD Other SEC-generated Letter 2016-10-17
  12. UPLOAD Other SEC-generated Letter 2016-10-06
  13. UPLOAD Other SEC-generated Letter 2016-09-15

Page 3 of 3 · 52 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…